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A*STAR, SingaporeABSTRACT Cyclic 3050 adenosine monophosphate (cAMP)-dependent-protein kinase (PKA) signaling is a fundamental reg-
ulatory pathway for mediating cellular responses to hormonal stimuli. The pathway is activated by high-affinity association of
cAMP with the regulatory subunit of PKA and signal termination is achieved upon cAMP dissociation from PKA. Although steps
in the activation phase are well understood, little is known on how signal termination/resetting occurs. Due to the high affinity of
cAMP to PKA (KD ~ low nM), bound cAMP does not readily dissociate from PKA, thus begging the question of how tightly bound
cAMP is released from PKA to reset its signaling state to respond to subsequent stimuli. It has been recently shown that phos-
phodiesterases (PDEs) can catalyze dissociation of bound cAMP and thereby play an active role in cAMP signal desensitization/
termination. This is achieved through direct interactions with the regulatory subunit of PKA, thereby facilitating cAMP dissocia-
tion and hydrolysis. In this study, we have mapped direct interactions between a specific cyclic nucleotide phosphodiesterase
(PDE8A) and a PKA regulatory subunit (RIa isoform) in mammalian cAMP signaling, by a combination of amide hydrogen/deute-
rium exchange mass spectrometry, peptide array, and computational docking. The interaction interface of the PDE8A:RIa com-
plex, probed by peptide array and hydrogen/deuterium exchange mass spectrometry, brings together regions spanning the
phosphodiesterase active site and cAMP-binding sites of RIa. Computational docking combined with amide hydrogen/deuterium
exchange mass spectrometry provided a model for parallel dissociation of bound cAMP from the two tandem cAMP-binding
domains of RIa. Active site coupling suggests a role for substrate channeling in the PDE-dependent dissociation and hydrolysis
of cAMP bound to PKA. This is the first instance, to our knowledge, of PDEs directly interacting with a cAMP-receptor protein in a
mammalian system, and highlights an entirely new class of binding partners for RIa. This study also highlights applications of
structural mass spectrometry combined with computational docking for mapping dynamics in transient signaling protein com-
plexes. Together, these results present a novel and critical role for phosphodiesterases in moderating local concentrations of
cAMP in microdomains and signal resetting.INTRODUCTIONCyclic 3050 adenosine monophosphate (cAMP) is an impor-
tant second messenger that is involved in relaying hormonal
stimulation of membrane-bound G-protein-coupled recep-
tors inside eukaryotic cells (1). cAMP levels are controlled
both by G-protein-coupled-receptor-mediated activation of
adenylyl cyclases, which synthesize cAMP from ATP (2),
and cyclic nucleotide phosphodiesterases (PDEs),which cata-
lyze hydrolysis of cAMP to 50AMP (3). Even though cAMP is
synthesized by adenylyl cyclases that are predominantly at the
plasma membrane, it does not diffuse uniformly throughout
the cell and instead exists in pools or microdomains (3–5).
This has been attributed to diverse PDEs that function to limit
cAMP diffusion. PDEs constitute a superfamily of enzymes
with 11 families in mammals, consisting of cyclic 3050 guano-
sine monophosphate (cGMP)-specific, cAMP-specific, and
dual specific types. Of the cAMP PDEs, the PDE4 family
has been most extensively characterized both in its enzy-Submitted March 14, 2014, and accepted for publication July 15, 2014.
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0006-3495/14/09/1426/15 $2.00mology and in its interactions with other proteins or lipids
to form large signaling complexes (6–10). Numerous studies
have also shown unique targeting modes of diverse PDEs to
distinct microdomains (11–13). An important basis proposed
to account for the limited cAMPdiffusion is via channeling of
cAMP from cyclases to PDEs through the cAMP receptors in
large macromolecular complexes (14).
cAMP binds to a diverse array of target proteins including
protein kinase A (PKA), guanine exchange factor protein,
cAMP-regulated bacterial transcription factors, and cyclic
nucleotide-gated ion channels. The common feature in all
of these diverse receptors is a highly conserved cAMP-bind-
ing domain (CNB), with a distinctive architecture and recog-
nizable sequence of invariant residues critical for cAMP
binding (15).
PKA is one of the most important targets for cAMP in eu-
karyotes (16) where the signaling cycle can be divided into
activation and termination phases (Fig. 1). The regulatory
(R) subunits of PKAexist as dimers, with eachmonomer con-
taining a tandem array of CNB domains (referred to as CNB-
A and CNB-B). Of all the CNB domain-containing proteins,http://dx.doi.org/10.1016/j.bpj.2014.07.050
FIGURE 1 Role of PDEs in signal termination
of PKA-mediated cAMP pathway: The cAMP-
PKA signaling pathway can be divided into Acti-
vation and Termination phases. Activation phase:
In the presence of cAMP (yellow) and a kinase
substrate (orange), the inactive PKA holoenzyme
dissociates to yield the cAMP-bound PKA R-sub-
unit (blue) and the active PKA C-subunit (purple).
Termination phase: The role of PDEs in cAMP
signal termination was demonstrated with the
PDE, RegA (38,40). PDEs (green) mediate direct
interactions with PKA R-subunit to hydrolyze
cAMP bound to both CNB domains of PKAR.
The resulting cAMP-free (apo) PKAR (green) is
primed for reassociation with PKA C-subunit
to form the inactive PKA holoenzyme. How
PDEs interact with the R-subunit (RIa isoform)
and catalyze hydrolysis of cAMP bound to the
R-subunit to 50AMP is unknown and a focus
of this study (highlighted in red). We hypothe-
size that PDEs bind cAMP-bound RIa more
tightly (ternary complex) than cAMP-free RIa
(end-state complex). Space-filling models based
on coordinates of structures of the different
proteins are indicated. C-subunit (PDB:1ATP),
R-subunit (cAMP-bound PKA RIa(113–379)
(PDB:1RGS)), and RIa(91–379):C complex (PDB:2QCS). Only the monomeric deletion fragment of PKA RIa (residues 113—379) is shown.
Apo RIa (green) is modeled on the structure of RIa (91–379) bound to PKA C-subunit (PDB:2QCS).
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ogous CNB domains, whereby cooperative binding of cAMP
to the twoCNB domains initiates the activation phase. This is
achieved through cAMP-dependent dissociation of the R-
subunit from the catalytic (C) kinase core of PKA, leading
to enhanced phosphorylation of numerous PKA cellular sub-
strates (16). PKAhas been the focus of extensive biochemical
and structural studies and these have provided valuable snap-
shots of the stable endpoint conformations of inactive PKA
holoenzyme and free active kinase (C-subunit) and cAMP-
bound R-subunit (16–21). The molecular basis for cAMP
action has been derived from dynamics studies by nuclear
magnetic resonance (17,22–28) and hydrogen/deuterium
exchange mass spectrometry (HDXMS) (29–31), aided by
phosphorothioate analogs of cAMP (32,33). These studies
have shown that the CNB domains in the R-subunit of PKA
populate a continuum of conformations in solution wherein
C-subunit and cAMP shift the equilibrium in separate
directions to favor distinct endpoint conformations (33).
This mode of action of cAMP is consistent with the con-
formational-selection model for ligand-mediated allostery
(34,35). Furthermore, dynamics have revealed that the two
cAMP-binding sites are coupled, where cAMP binding to
CNB-B leads to enhanced dynamics in CNB-A, when the
binding pocket is disrupted by a pointmutation. This provides
an explanation for positive cooperativity in cAMP action
(36). Together, these studies underscore how cAMP-induced
changes in dynamics in PKA are critical for its function. All
of these studies have focused entirely on the activation phase
whereas the termination phase is poorly understood.How the cAMP:PKA signaling system resets itself by re-
generating inactive PKA holoenzyme can be defined as the
resetting/termination phase. cAMP binds the PKA R-subunit
with strong affinity (~2–10 nM) (37). How this tightly bound
cAMP dissociates from its target R-subunit to allow for
completion of the cAMP signaling cycle is an important mys-
tery in cAMP signaling and is essential for signal termination.
cAMPdissociation is critical to allow reassociation of PKAR-
subunit with the C-subunit and resetting of the system through
formation of the inactive PKA holoenzyme. A role for PDEs
in termination by catalyzing hydrolysis of bound cAMP has
come from recent studies with a cAMP PDE from Dictyoste-
lium discoideum, RegA (38). D. discoideum represents an
importantmodel for cAMP signal termination because it lacks
the complexity of isoforms in PKA and PDEs (39).
In this simpler system, the cAMP PDE RegA is capable of
mediating dissociation and hydrolysis of cAMP bound to a
PKA R-subunit through direct interactions (40) (Fig. 1).
This is a critical step inasmuchas cAMPremains tightly bound
to the R-subunit and shows negligible dissociation rates
(41,42) in the absence of the C-subunit. The R-subunits
thereby function to buffer intracellular cAMP and this is
hydrolyzed throughdirect interactionswith PDEs.This hydro-
lysis of bound cAMP is necessary for the R-subunit (RIa iso-
form) to reassociate with the C-subunit and reset the system
through formation of the PKA holoenzyme (38). Indirect in-
teractions of PDEs with PKA have been identified through
the action of A-kinase anchoring proteins (AKAP) targeting
proteins, which have been shown to localize PDEs and PKA
(43–46). A direct role for PDEs in cAMP signal terminationBiophysical Journal 107(6) 1426–1440
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However, the nature of direct PDE-RIa interactions is
completely unknown. Furthermore, no such interactions
have been reported in mammalian cAMP signaling, whose
complexity arises from myriad types/isoforms/splice variants
of PDEs (3) and PKA.
In this study, we report a mammalian PDE:PKA RIa com-
plex through an integrated approach combining structural
mass spectrometry and fluorescence spectroscopy with com-
putational methods. Although localization of PDEs with
PKA R-subunits have been observed with specific classes of
AKAPs (43), we describe, for the first time to our knowledge,
AKAP-independent interactions between PKA and PDEs in a
mammalian system. We also describe a mechanism for PDE-
mediated dissociation of cAMP from the two binding sites on
the R-subunit. The binding interface residues on RegA, map-
ped byHDXMS,were used to computationally identify PDE8
as a cAMP:PDE interacting partner; this was further validated
by cAMP dissociation assays. A combination of HDXMS and
computational docking was then used to map and model the
PDE8:RIa interface. The power of computational docking
has been greatly improved by combination with HDXMS,
which provides experimental filters for narrowing the solu-
tions for protein interfaces. This methodology has previously
been used for mapping protein-protein interactions (47,48)
and protein:DNA interactions (49). The PKA R-subunit is
highly modular and is composed of an N-terminal dimeriza-
tion domain, a pseudosubstrate site and two tandem CNB do-
mains (18). The CNB domains are capable of functioning as
high-affinity binders of both cAMP and the C-subunit in the
absence of the dimerization domain. This hasmade it possible
to use monomeric deletion mutant constructs of the pseudo-
substrate region with CNB-A alone (residues 91–244) or as
a construct spanning both CNB domains A and B together
with the pseudosubstrate region (residues 75–379) for detailed
mapping of PDE-R-subunit interactions. These are referred to
as RIaA and RIaAB, respectively. Of the two PDE8 isoforms,
we have used full-length PDE8A in this study or a deletion
mutant spanning its catalytic domain (residues 472–829),
henceforth referred to as PDE8AC.
Our results provide a minimal model to describe how a
phosphodiesterase, PDE8, catalyzes hydrolysis of cAMP
tightly bound to RIa. These results also provide a basis
for how PDE-cAMP-receptors might form extended macro-
molecular complexes functioning as regulatory barriers for
cAMP diffusion. PDEs we believe, are thus an entirely
new class of RIa-interacting partner proteins involved in a
novel mechanism for cAMP signal termination.EXPERIMENTAL PROCEDURES
Materials
Unless otherwise mentioned, all reagents were from Sigma Aldrich
(St. Louis, MO). BL21 (DE3) Escherichia coli strains were from NovagenBiophysical Journal 107(6) 1426–1440(Madison, WI). Glutathione Sepharose 4B and NHS-activated Sepharose 4
Fast Flow were obtained from GE Life Sciences (Chicago, IL). 8-AEA-
cAMP was from Biolog Life Science Institute (Bremen, Germany); TFA,
protein sequence analysis grade, was from Fluka BioChemika (Buchs,
Switzerland); and the Poroszyme-immobilized pepsin cartridge was from
Applied Biosystems (Foster City, CA). Purified recombinant GST-tagged
PDE2A (catalog No. 60020), PDE5A (catalog No. 60050), PDE8A (catalog
No. 60080), and PDE9A (catalog No. 60090) were purchased from
BPS Bioscience (San Diego, CA). Recombinant GST-tagged PDE8A
(1 mg/mL) was also obtained from Signal Chem (Richmond, British
Columbia, Canada) for HDXMS experiments.Subcloning of PDE8AC and full-length RIa into
pETDuet-1 vector
Oligonucleotide primers for PDE8A catalytic domain spanning residues 472–
829, were designed using codon-optimized Human PDE8A1 synthetic gene
as a template (DNA 2.0; Menlo Park, CA). The DNA fragments were ampli-
fied by polymerase-chain reaction and subcloned using BamHI and NotI re-
striction enzymes into a multiple cloning site 1 (MCS1) of the pETDuet-1
vector containing a hexahistidine tag, N-terminal to the protein sequence.
Full-length RIa was cloned into a multiple cloning site 2 (MCS2) of the
pETDuet-1 vector using the NdeI and KpnI restriction enzymes.Protein expression and purification
PDE8AC has been expressed in E. coli but is insoluble and present in inclu-
sion bodies (50). We hypothesized that coexpression of full-length RIawith
PDE8AC in E. coli BL21 (DE3) cells might aid solubility of PDE8AC.
Although some of the PDE8AC was found to be soluble, most of it was still
present in inclusion bodies. To improve yields of soluble PDE8AC, refold-
ing of inclusion bodies with denaturants was carried out. Thus, the pellet
with insoluble PDE8AC was denatured by 6 M guanidinium hydrochloride
and the solubilized PDE8AC was purified by affinity chromatography using
Cobalt affinity His-Tag resin (Clontech Laboratories, Mountain View, CA).
PDE8AC was refolded by a previously described protocol in Yan et al. (50),
with the only modification being that the Hexahistidine tag was not
removed by thrombin cleavage. Refolded PDE8AC showed the same activ-
ity as reported in Yan et al. (50).
cAMP affinity chromatography resin for R-subunit purification was syn-
thesized by coupling 8-AEA-cAMP to the NHS-activated Sepharose 4 Fast-
Flow beads according to manufacturer specifications (GE Life Sciences,
Singapore) (51). Both cAMP-bound and cAMP-free RIaA were expressed
and purified as described previously in Anand et al. (52). cAMP-bound
RIaAB was expressed and purified by cAMP affinity chromatography resin
similar to RIaA. The cAMP-free RIaAB was prepared by the dissociation of
cAMP by urea stripping and refolding (53). RegA (385–780) (RegAC) was
expressed as a GST fusion protein in E. coli BL21*(DE3). The protein was
purified using glutathione Sepharose 4B (GE Life Sciences) according to
manufacturer specifications followed by size exclusion-gel filtration chro-
matography on an AKTA system (GE Life Sciences) (38).Fluorescence polarization assay for cAMP
dissociation
Todeterminewhether allPDEswere capable of dissociatingboundcAMPfrom
RIa, we carried out a fluorescence polarization (FP) assay using 8-Fluo-cAMP
(8-(2-[fluoresceinyl]aminoethylthio)adenosine- 30,50- cyclic monophosphate)
saturated RIaA as described in Moorthy et al. (38) with PDEs 2A,5A, 8A,
and 9A. A Synergy 4 Multi-Detection microplate reader (Biotek, Winooski,
VT) was used in FPmode for the plate reader assays. The excitation and emis-
sion wavelengths used were 485 and 528 nm, respectively, with a bandwidth
of 20 nm with an instrument G-factor of 0.87. Ninety-six-well black plates
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0.12 mM of 8-Fluo-cAMP-bound RIaA in buffer A (20 mM Tris-HCl, pH
7.5, 50 mM NaCl, 10 mM MgCl2, and 5 mM BME) were monitored in the
presence of a 10-fold molar excess of PDE and were repeated with equimolar
PDE8A.FPmeasurementswere takenat time intervals of 2minup to45min. In
all samples, 0.5 mM cAMP/10 mM cAMP/cGMPwas added at 18 min.When
excess PDE was used to monitor FP, 0.5 mM cAMP was used to saturate the
reactionwhereas 10mMof cAMP/cGMPwas usedwhen lower concentrations
of PDE8Awere tested subsequently. Data from early time points (0–18 min)
were fit to a one-phase exponential decay equation using the softwareGRAPH-
PAD PRISM, Ver. 5 (GraphPad, San Diego, CA).Amide hydrogen/deuterium exchange mass
spectrometry
To carry out amide hydrogen/deuterium exchange mass spectrometry
(HDXMS) experiments of the GST-RegAC:RIaA complex, 50 mL of
20 mM GST-RegAC and 60 mM cAMP-free RIaA (1:3 molar ratio) were
incubated at room temperature for 30 min.
HDXMS experiments with the full-length PDE8A1:RIaAcomplex were
carried out maintaining sample concentration at 6 mM of PDE8A1 and
42 mM of cAMP-free RIaA (1:7 molar ratio) in a total reaction volume of
4 mL for each HDXMS experiment.
HDXMS experiments of the PDE8AC:RIaAB complex were carried out
in two ways: 1), to maintain saturating amounts of RIaAB and maintain
all available PDE8AC in complex form, 30 mM of PDE8AC was incubated
with 90 mM cAMP-bound RIaAB (1:3 molar ratio) for 1 h on ice; and 2), for
the inverse experiment, where saturating amounts of PDE8AC are main-
tained so all available RIaAB is in complex form, 30 mM of cAMP-bound
RIaAB was incubated with 100 mM of PDE8AC (1:3.3 molar ratio) for
1 h on ice. Incubating cAMP-bound RIaAB with PDE8AC was carried out
to obtain the end-state complex of cAMP-free RIaAB bound to PDE8AC.
An incubation time of 1 h was determined to be optimal, from HDXMS-
based real-time reaction monitoring experiments, for complete PDE8AC-
mediated cAMP dissociation from RIaAB. These experiments showed
that all available cAMP bound to RIaAB was dissociated and hydrolyzed
within 30 min by PDE8AC action, resulting in cAMP-free RIaAB bound
to PDE8AC. This was observed even when RIaAB was at 3 higher molar
concentration to PDE8AC (S. Krishnamurthy, N. K. Tulsian, and G. S.
Anand, unpublished results). Control HDXMS experiments with cAMP-
free RIaAB were carried out with urea-stripped and refolded RIaAB.
All samples were allowed to equilibrate to room temperature before
deuterium exchange experiments. Deuterium exchange was carried out by
diluting the samples in storage buffer (20 mM Tris-HCl, pH 7.5, 50 mM
NaCl, 10 mMMgCl2, and 5 mMBME) 15 for RegA:PKAR-subunit com-
plex in D2O (99.90%), resulting in a final concentration of 93.3% deuter-
ated buffer. For PDE8A:RIaAB complexes (both full-length PDE8A and
PDE8AC), samples were diluted 10 in storage buffer, resulting in a final
concentration of 90% deuterated buffer.
Exchange was carried out at 20C for various labeling times (0.5, 1, 2, 5,
and 10 min). For initial experiments with full-length PDE8A, only a single
labeling time of 2 min was carried out. The exchange reaction was
quenched by addition of prechilled 0.1% TFA to obtain a final pHread of
2.5. Fifty microliters of the quenched sample was then injected on to a
chilled nano-UPLC sample manager (Waters, Milford, MA) as previously
described in Wales et al. (54). The sample was washed through a 2.1 
30-mm immobilized pepsin column (Porozyme; ABI, Foster City, CA) us-
ing 100 mL/min 0.05% formic acid in water. The digest peptides were
trapped with a 2.1  5 mm C18 trap (ACQUITY BEH C18 VanGuard
Pre-column, 1.7 mm; Waters). Peptides were eluted using an 8–40%
gradient of acetonitrile in 0.1% formic acid at 40 mL/min, supplied by a
nanoACQUITY Binary Solvent Manager (Waters), into a reverse phase col-
umn (ACQUITYUPLC BEHC18 Column, 1.0 100 mm, 1.7 mm;Waters)
for resolution. Peptides were detected and mass-measured on a SYNAPT
HDMS mass spectrometer (Waters) acquiring in MSE mode (55,56).Peptides were identified from MSE data of undeuterated samples using
the PROTEINLYNX GLOBAL SERVER (PLGS 2.4; Waters) (57,58).
Identifications were only considered if they appeared at least twice out of
three replicate runs and had a minimum of four digest fragment ions. These
identifications were mapped onto subsequent deuteration experiments using
prototype custom software (DYNAMX Ver. 2.0; Waters). Data on each
individual peptide at every time point was extracted and analyzed using
this software. Instrument calibration was carried out as described in Anand
et al. (32) and Moorthy et al. (36). Reported values for all HDXMS exper-
iments are the average of at least two independent deuterium exchange
experiments.Docking
The model of PKA RIaAB bound to PDE8AC was generated using the
HADDOCK web server (59). The available crystal structures of dimeric
PDE8AC (PDB:3ECN) and the cAMP-bound conformation of RIa
(PDB:1RGS) were considered as starting structures for the docking.
Because the linker between the two cAMP domains of RIa is highly flex-
ible, leading to potentially large conformational changes upon binding
PDE8, RIa was split into two CNB domain fragments, namely
RIa_CNB-A (residues 113–235) and RIa_CNB-B (residues 241–379)
and docked independently. The active residues that drive the docking calcu-
lations were selected based on regions showing decreased deuterium ex-
change upon complexation with PDE8. Because this region outlined by
the experiment was large and includes residues that are buried in the static
crystal structure, we only selected a subset of residues that were solvent-
exposed as the input for docking. The residues around the active residues
were considered passive (the default option). The C- and N-termini were
kept uncharged inasmuch as they were not the actual termini. The residues
230–235 in RIa_CNB-A and 241–250 in RIa_CNB-B were treated as fully
flexible. For each run, 1000 structures, in total, were calculated by rigid-
body minimization of the docking score. Semiflexible simulated annealing
followed by refinement in explicit water was performed for the best 200
solutions based on the HADDOCK score. The calculated models were clus-
tered using a 7.5 A˚ interface root-mean-square deviation cutoff.
The following residues were defined as ambiguous interaction restraints
to drive the docking:
PDE8A residues
526, 527, 529, 530, 531, 532, 609, 610, 611, 621, 622, 651, 652, 653, 681,
682, 683, 686, 687, 690, 691, 693, 694, 696, 698, 699, 700, 702, 703, 706,
756, 759, 760, 761, 762, and 763.
RIa (CNB-A) residues
128, 131, 132, 133, 134, 171, 177, 178, 179, 189, 191, 194, 196, 197, 199,
200, 201, 204, 205, 206, 207, 208, 210, 216, 217, and 218.
RIa (CNB-B) residues
268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 322, 323, 324, 325,
328, 329, 330, 331, 332, 333, 334, 335, 336, 354, 355, 356, 358, 359, 361,
362, and 363.Selection of the docked pose
The binding models of the CNB-A and CNB-B to the PDE8AC dimer from
the docked poses of two independent runs were picked based on the
following criteria:
1. The quality of RIa contacts with the PDE8AC (using the native
HADDOCK score),
2. The accessibility of the RIa-bound cAMP to the catalytic site of the
PDE8AC, andBiophysical Journal 107(6) 1426–1440
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domains was consistent with the fact that the two are connected by the
RIa linker a:C-helix in vivo.
Criterion 2 was quantitated in an ad hoc way by counting the number of
peptide atoms inside the sphere that can be inscribed between the centers
of the cAMP-binding pockets in PDE and RIa. Namely, if our model is cor-
rect, we expect that the cAMP-binding pockets in the two proteins should
be mutually accessible, allowing the transfer of the substrate between the
two. Thus, we looked for a configuration of the complex in which as few
peptide atoms as possible appear in the space between the two pockets. Cri-
terion 3 was tested by manually modeling the central helix into the model of
the complex.RESULTS
The RIa CNB:A-RegAc interface by HDXMS
encompasses the PDE catalytic active site
We previously showed that the catalytic domain ofD. discoi-
deum RegA (RegAC) was capable of interacting with the
mammalian PKA R-subunit (RIa) to dissociate bound
cAMP and hydrolyze it to 50AMP (38). Because PKAR-sub-FIGURE 2 Summary of peptide array analysis and HDXMS of RIa:RegAc in
for the catalytic domain of RegAmapped onto the homology-modeled PDE struc
SWISS-MODELER. (Blue) Peptide fragments showing decreased exchange (af
showing no difference; (dark gray) regions with no pepsin-digest fragment co
the homology-modeled PDE structure of PDE8A (PDB:3ECN). (Red) Peptides s
array results mapped onto the structure of homology-modeled PDE8. (Blue regio
regions) intersection sites. In addition to Zn2þ and Mg2þ, the nonspecific PDE
(stick representation). (D) Results from HDXMS of RegAC:RIaA interactions ar
ture. The inhibitor IBMX is shown in stick representation (yellow). (E) Evolut
structure of the cGMP phosphodiesterase PDE9 (PDB:2HD1).
Biophysical Journal 107(6) 1426–1440units have two CNB domains, initial experiments used the
single domain CNB-A construct and mapped the binding
site for RegAC (38), which overlapped with the cAMP-bind-
ing site (40). Herewemapped the complementary interaction
surface on RegAC by a combination of peptide array and
HDXMS (see Fig. S1 and Fig. S2 in the SupportingMaterial).
The results enabled a detailed map of the interface that en-
compassed the PDE active site when modeled onto the struc-
ture of a close cAMP PDE homolog of RegA, PDE8A
(PDB:3ECM) using the software SWISS-MODELER
(Fig. 2, A–C, and see the Supporting Material) (60,61).PDE-RIa interaction interface shows broad
conservation across the PDE superfamily
The binding site for RegA on PKA RIa identified by
HDXMS and peptide array (Fig. 2, D and E) spanned the
RegA catalytic site, which is highly conserved across all
PDEs. This suggested PDE:PKA RIa complexes might be
conserved in mammalian cAMP signaling wherein one orteractions mapped onto the structure of PDE8A. (A) Results from HDXMS
ture of the closest cAMP PDE homolog of RegA, PDE8 (PDB:3ECN) using
ter 10 min deuterium exchange) in the presence of RIaA. (White) Regions
verage. (B) Results from peptide array analysis for RegAC mapped onto
howing direct interactions with RIa. (C) Composite of HDXMS and peptide
ns) Decreased exchange; (red regions) peptide array fragments; and (green
inhibitor, IBMX (3-isobutyl-1-methylxanthine) is shown in panels B and C
e mapped (red) onto the surface representation of the modeled RegA struc-
ionary trace analysis of RegA:RIaA interaction interface mapped onto the
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functional interactions with PKA R-subunits including
RIa. To examine this further, we carried out a comprehen-
sive primary sequence analysis based on sequence conser-
vation and exon-intron structure, to identify putative
mammalian homologs of RegA from within the PDE super-
family (see Fig. S3 and Fig. S4). These analyses revealed a
strong sequence conservation in RIa interaction regions,
which also overlapped with the highly conserved phospho-
diesterase active sites. If we narrowed down the sequence
homology to just the catalytic domains alone, we found to
our surprise the closest mammalian PDE homolog to be a
cGMP-specific PDE, PDE9. This was intriguing as it high-
lighted a possible route for cross-talk between cGMP and
cAMP signaling. The next-nearest homologous catalytic
domain was the cAMP PDE, PDE8. Interestingly, the
domain organization of PDE8A shows parallels with
RegA, in containing a putative N-terminal response regu-
lator domain (receiver domain) (39,62).FIGURE 3 PDE8A interacts with RIa and blocks cAMP reassociation.
(A) Dissociation of 8-fluo-cAMP from RIaA(0.12 mM) was monitored by
measuring the fluorescence polarization (FP) change in the presence of a
molar excess (1.2 mM) of the following phosphodiesterases () PDE2A,
(C) PDE8A, (D) PDE5A, and (V) PDE9A. Interpolated FP values are
plotted versus time; (arrow) addition of cAMP (0.5 mM) after 18 min to
all reactions. Baseline signal for 8-fluo-cAMP (0.12 mM) (B). (B) Disso-
ciation of 8-fluo-cAMP from RIaA(0.12 mM) was monitored by measuring
the FP change in the presence of 0.13 mMPDE8A (C) and IBMX-saturated
PDE8A (); (arrow) addition of cAMP (10 mM) or cGMP (10 mM) (:)
after 18 min of the reaction. Baseline signal for 8-fluo-cAMP (0.12 mM)
(B) and PDE8A (0.12 mM) (,)Rapid screening of PDE-RIa interactions by
fluorescence polarization spectroscopy
To test the potential broad specificity of PDE interactions
with RIa, we used Fluorescence polarization spectroscopy
(FP)with 8-fluo-cAMP (8-(2-[fluoresceinyl]aminoethylthio)
adenosine- 30,50- cyclicmonophosphate) as a rapid screen for
identifying potential PDEs that are capable of dissociating
cAMP bound to the PKA R-subunit. We chose four full-
length PDEs (PDE9A, PDE8A, PDE2A, and PDE5A) to
test for dissociation of cAMP bound to the CNB-A domain
of RIaA. To broaden the search for possible mammalian
homologs of RegA, we also included two classes of cyclic
nucleotide-binding GAF-domain regulated PDEs, PDE5A
(cGMP-specific) and PDE2A (cAMP/cGMP dual speci-
ficity) for testing interactions with RIa. FP assays with 8-
fluo-cAMP -labeled RIaA were carried out as described in
Moorthy et al. (38). 8-fluo-cAMP is resistant to PDE
hydrolysis and therefore offered an opportunity for direct
monitoring of cAMPdissociation fromRIa (63). No intrinsic
dissociation of 8-fluo-cAMPwas observable fromCNB-A of
RIa in the absence of either excess cAMP or excess PDE.
This is a consequence of a slow kinetic off-rate for cAMP
from the R-subunit or fast reassociation rate of released
cAMP, and was used as a basis for testing the ability of
PDEs to dissociate cAMP bound to CNB-A in RIaA.
In the presence of a 10 molar excess of full-length
PDEs, small increases in FP values were observable with
time in the presence of PDEs 5A and 8A. This can be
attributed to the ability of PDEs to bind 8-fluo-cAMP
despite being incapable of readily hydrolyzing it (63).
Even though equivalent analogs resulting from substitu-
tions at the 80 position of the adenine ring such as
8-Br-cAMP confer resistance to PDE hydrolysis, they
nevertheless are capable of binding and functioning ascompetitive inhibitors of PDEs. Addition of PDE2A re-
sulted in a steady increase in fluorescence polarization
with time (Fig. 3 A) . This increase in FP is consistent
with 8-fluo-cAMP functioning as a cAMP analog and bind-
ing the GAF domain of PDE2. Regardless of how 8-fluo-
cAMP might interact with PDEs, the increase in FP upon
addition of PDEs 2A, 5A, and 8A could only occur upon
its dissociation from RIaA.
To measure the ability of cAMP to competitively displace
8-fluo-cAMP from RIaA, a vast excess of cAMP (0.5 mM)
was added and the FP signal monitored. The addition of
excess cAMP after 18 min showed important differences
between the cGMP-specific and cAMP-specific PDEs.
This time point was chosen for addition of cAMP based
on our previous observations, where addition of RegA
PDE resulted in a complete drop in FP within 10 min
(38). cAMP addition was carried out at this time point
(18 min) to allow possible PDE-mediated dissociation to
be fully completed before introducing excess cyclic nucleo-
tides in the reaction. Samples containing PDEs 5A and 9ABiophysical Journal 107(6) 1426–1440
1432 Krishnamurthy et al.showed a steady drop in FP up to time t ¼ 40 min when it
reached baseline, upon addition of cAMP. Because cAMP
is hydrolyzed poorly by cGMP PDEs, all of the 8-fluo-
cAMP bound to RIa is displaced by excess unhydrolyzed
cAMP and this is reflected in the drop in FP.
The sample containing PDE8A showed a more gradual
drop in FP upon addition of cAMP up to time t ¼
28 min, after which it increased to a steady intensity at
time t ¼ 32 min, equivalent to the signal at time t ¼
18 min before the addition of cAMP. PDE8A rapidly
hydrolyzes the excess cAMP added to 50AMP and once
the cAMP is depleted, 8-fluo-cAMP reassociates with
PDE8A to increase the FP signal (Fig. 3 A). All the
PDEs we tested, with the exception of PDE9A, were
capable of interactions with RIaA resulting in dissociation
of cAMP. Although these results do not exclude PDEs 2A
and 5A as potential RIaA binders, we chose to explore
these PDE8A:RIaA interactions further, given its higher
homology with RegA.PDE8A interacts with RIa and facilitates cAMP
dissociation
We next carried out FP assays at lower concentrations
of PDE8A ((0.13 mM), 1:1 molar ratios). At these lower
concentrations, we observed that PDE8A alone showed
no changes in FP, suggesting that it did not bind 8-fluo-
cAMP (Fig. 3 B). These conditions therefore allowed
monitoring of cAMP dissociation by PDE8A. Our results
showed that PDE8A promotes dissociation of 8-fluo-
cAMP both in the presence and absence of the nonspecific
PDE inhibitor IBMX (3-isobutyl-1-methyl xanthine). Upon
addition of excess cAMP, a larger dip in the FP signal was
observed for IBMX-bound PDE8A. This reflects slower
cAMP hydrolysis in the presence of IBMX and conse-
quently a lag in reassociation of released 8-fluo-cAMP to
RIa (Fig. 3 B).
PDE assays showed that PDE8Awas capable of hydrolyz-
ing cAMP bound to RIaA with cAMP-bound RIaA as the
sole substrate (see Fig. S5). This is consistent with previous
results obtained with RegA (38). We then set out to examine
the interactions of the catalytic domain of PDE8A with the
CNB domains of PKA R-subunit in greater detail.Catalytic domain of PDE8A interacts with both
cAMP-binding domains of RIa
Having shown that PDE8A was capable of dissociating
cAMP bound to RIaA, we set out to map complexes of
PDE8A with RIaA and compare it with RegA:RIaA com-
plex. Full-length PDE8A was complexed with cAMP-free
RIaA and HDXMS was carried out on the complex, as
described in the Experimental Procedures. Given that the lo-
cus of interactions between RIaA and RegA was entirely
within the RegA catalytic domain (38), deuterium exchangeBiophysical Journal 107(6) 1426–1440analysis for PDE8A was restricted to the catalytic domain.
Twenty-four peptides, total, were analyzed corresponding
to a sequence coverage of 72% for the catalytic domain (res-
idues 480–818). Four regions showed decreased deuterium
exchange upon binding to RIaA (see Fig. S6). The regions
span residues 527–547 of H4 and H5, 619–648 of H10,
765–781 of the M-loop, and 685–706 on HE1 and HE2.
Of these regions, three are proximal to the catalytic site
whereas residues 685–706, represented by two contiguous
peptides, are located on a helix loop helix motif (HE1 and
HE2) unique to PDE8 (61).
For improved resolution of the PDE8-RIa interface, we
then focused on the catalytic domain of PDE8A, PDE8AC.
Size-exclusion chromatography of PDE8AC showed two
peaks representing a dimer and monomer with a concentra-
tion-dependent elution of a majority of PDE8AC as a dimer
(data not shown). Given that PDE8A and other PDEs exist
as dimers in solution (3), we tested for how a PDE dimer
(PDE8AC) might engage both CNB domains in RIa. We
therefore set out to map interactions by HDXMS with an
expanded monomeric RIa fragment containing both CNB
domains (RIaAB) with dimeric PDE8Ac.
Sixty-nine peptides, total, were observed and analyzed by
HDXMS, which corresponds to a coverage of 81% of the
primary sequence of PDE8AC. On PDE8AC, regions span-
ning the conserved catalytic residues showed decreased ex-
change in the PDE8AC:RIaAB complex (Figs. 4 and 5), and
overlapped with the regions that showed decreased ex-
change in full-length PDE8A.
In the converse HDXMS experiment to map the interac-
tion of PDE8AC onto the surface of RIaAB in the RIaAB:
PDE8AC complex, 49 peptides were observed and quanti-
fied, corresponding to a coverage of 80% of the primary
sequence of RIaAB. The RIaAB:PDE8AC complex was
generated by incubating RIaAB with a 3 molar excess of
PDE8AC for 1 h to ensure all the cAMP bound is fully disso-
ciated from the complex. Interestingly, results for RIaAB
showed decreased exchange at both cAMP-binding sites
(CNB-A and CNB-B) and across regions connecting these
two domains (Figs. 6 and 7). Sites showing the greatest
shifts in deuterium exchange upon complexation with
PDE8AC thus were not only at the binding sites but also
at flanking allosteric sites important for propagation of the
effects of cAMP binding. Importantly, N-terminal regions
of RIaAB spanning the PKA pseudosubstrate site showed
only minor changes in deuterium exchange upon complex-
ation with PDE8AC. (See Table S1 and Table S2 in the
Supporting Material summarizing deuterium exchange for
all the peptides from PDE8AC and RIaAB.)
The effects of cAMP binding on RIaAB (Fig. 8 A, top
panel) were different from the effects of PDE complexation
(Fig. 6, bottom panel). This is summarized in Fig. 8 A (bot-
tom panel). cAMP-binding results in large-magnitude de-
creases in deuterium exchange, which are primarily within
the specific binding pockets in CNB-A and CNB-B. The
FIGURE 4 Proteinwide overview of interaction of RIaAB on PDE8AC. (i) Mirror plot representation for comparative analysis of HDXMS of free PDE8AC
(catalytic domain) and in the presence of RIaAB. The relative deuterium exchange (y axis) of each pepsin digest fragment is listed from the N- to C-terminus
(x axis) of PDE8AC, with deuterium exchange times color-coded as per key. In this plot, relative deuterium exchange (y axis) of free PDE8AC (upper half) is
compared with relative deuterium exchange of PDE8AC in complex with RIaAB (lower half). (Bottom panel) Absolute difference in numbers of deuterons
(inferred from difference in mass in Daltons (Da) (y axis) between the free and complexed state is plotted for each pepsin digest fragment listed from the N- to
C-terminus (x axis) of PDE8AC for each deuterium exchange time point (t ¼ 0.5, 2, 5, 10 min) in a difference plot. Shifts in the positive scale represent
increases in deuterium exchange and shifts in the negative scale represent decreases in deuterium exchange. A difference of 0.5 Da is considered significant
(dashed red line). Plots were generated using the software DYNAMX (Ver. 2.0, Waters). Each point represents a pepsin digest fragment, and brackets group
the overlapping fragment peptides.
Channeling in cAMP Signal Termination by PDE-PKA Complexes 1433PDE8AC complexation, on the other hand, shows smaller
magnitude decreases in the cAMP-binding sites; however,
it also shows proteinwide decreases in deuterium exchange
(Fig. 8 B) and specifically in the N-terminus and the interdo-
main a:C helix.Model of PDE8A-RIa interface by computational
docking reveals both CNB domains of RIaAB are in
close proximity to PDE8AC catalytic site
Molecular docking was carried out to model the
PDE8:PKA RIa interface based on the HDXMS results.
Because size exclusion chromatography of PDE8AC indi-
cated a majority of PDE8AC existed as a dimer in solution,
and the PDE8 structure (PDB:3ECN) crystallized as a
dimer, the dimeric structure of the catalytic domain of
PDE8, was used for docking with monomeric RIa(113–
379) ((PDB:1RGS)). Such a complex would show a stoi-
chiometry of one PDE dimer interacting with one mono-
mer of RIa(113–379).
RIa exists in two distinct conformations: 1), bound to
PKA catalytic subunit (H-form), and 2), bound to cAMP
(B-form) (33,64). We hypothesize that the B-form ofRIa must interact with PDEs (ternary complex) for hydro-
lysis of the tightly bound cAMP, leading to cAMP signal
termination (Fig. 1). These can occur through a simulta-
neous interaction of the two cAMP-bound CNB-domains
or via tandem binding of each cAMP-bound CNB domain
to individual PDE units in the dimer. Because it is known
that the two cAMP-binding domains in RIa are connected
by a dynamic C-helix (36,65), we reasoned that the central
helix undergoes dynamic rearrangements, making accom-
modation of both CNB domains binding simultaneously
or in tandem equally plausible. Furthermore, mapping
of PDE8:RIa interactions by HDXMS suggests that the
PDE8-binding interface is symmetric, whereas differential
exchange across the two CNB domains of RIa is nonuni-
form. These are suggestive of an asymmetric interaction
surface across the individual CNB domains of RIa. To
factor in dynamics of the interdomain linker (64,66),
HADDOCK runs were set up in two different ways: The
cAMP-bound conformation of RIa (PDB:1RGS chain B)
was modeled as follows:
1. As one whole unit with a rigid helix linker, and
2. As two separate cAMP-binding domains sans the linker.Biophysical Journal 107(6) 1426–1440
FIGURE 5 Map of the interactions of RIaAB on PDE8AC. Effects of RIaAB interactions from HDXMS analysis mapped onto the dimeric structure of
PDE8AC (PDB:3ECN); IBMX at the active site is in green. (Shadings in blue, as per key) Regions of PDE8AC showing significant decreases in deuterium
exchange upon complex formation. Mass spectra of peptides showing significant changes upon RIaAB complex formation (difference>1 Da) are shown. The
isotopic envelopes of pepsin fragment peptides of (i) undeuterated control of PDE8AC, (ii) free PDE8AC after 2 min deuteration, and (iii) PDE8AC in a com-
plex with RIaAB after 2 min deuteration are depicted. Centroids are indicated (:).
1434 Krishnamurthy et al.In the latter runs, to circumvent the limitation of docking
programs in modeling large conformational changes, each
CNB domain was independently docked to mimic the
freedom that a flexible linker would provide. It is well estab-
lished that the solutions generated by HADDOCK are closer
to native complexes if the docking is driven by restraints
based on experimental data. In our case, these constraints
were provided by results from HDXMS. The changes in
deuterium exchange upon complexation in PDE8AC and
RIaAB are rendered in surface representation in Fig. 9, A
and B, respectively.
In our computational experiment, we first docked RIa as
a rigid unit. Upon inspection of the solutions, it was clear
that the two cAMP-binding domains cannot be made
simultaneously accessible to the catalytic sites of PDEs
(data not shown). It is conceivable that one of the RIa
cAMP-binding domains acts first; after it extracts the
cAMP, it is released, which enables the other cAMP-bind-
ing domain to bind to PDE. However, because the cAMP-
binding domains in RIa are highly homologous, and the
linker C-helix is highly dynamic (65), we proceeded to
investigate whether the geometry of the two proteins, aidedBiophysical Journal 107(6) 1426–1440with some flexibility in the central helix of RIa, could
allow simultaneous docking of the two domains. Thus, in
subsequent docking experiments, the two domains of
RIa were docked onto the PDE8 dimer individually. The
high structural similarity of the two domains suggests
that they could also bind to each of the PDE8 catalytic sites
in a quasi-symmetrical way.
It should be kept in mind that the scoring, and even
more so the ranking, in the computational reconstruction
of protein complexes remains problematic (67). Thus, we
used docking to generate geometrically feasible models
of the interaction proposed in this study, and used the
HADDOCK’s native score as guidance, but also as only
one of the constraints that the model should satisfy. The cho-
sen pose for CNB-B domain has the best HADDOCK score
of 37.55, whereas CNB-A with a HADDOCK score of
43.29 belongs to the top 8% in its class (Fig. 9 C). The num-
ber of intervening atoms (from Criterion 2, described earlier
in text) for CNB-B was among the top 3%, smallest in the
200 chosen poses, and for CNB-A among the top 30%, sug-
gesting that the degree of the conformational change might
be still larger than indicated by the model.
FIGURE 6 Proteinwide overview of interaction of PDE8AC on RIaAB. (i) Mirror plot representation for comparative analysis of HDXMS of free RIaAB
bound to PDE8AC. In this plot, relative deuterium exchange (y axis) of free RIaAB (upper half) is compared with relative deuterium exchange of RIaAB
complexed to PDE8AC (lower half). Difference plot (ii) shows the difference in absolute number of deuterons exchanged between the two states. Negative
values indicate decreased exchange upon complexation with PDE8AC. Plots were generated using the software DYNAMX (Ver. 2.0, Waters). Each point
represents a pepsin digest fragment and brackets group overlapping fragment peptides.
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In this study, we report the description of a signaling com-
plex of PDEs with PKA RIa through a combination of
orthogonal experimental and computational approaches.
This constitutes a fundamental signaling complex in the
termination or resetting phase of cAMP signaling. Our re-
sults support a universal model for how PDEs bind both
CNB domains of RIa and catalyze hydrolysis of bound
cAMP leading to signal termination, with broad conserva-
tion from Dictyostelia to mammals.PDE-PKAR-subunit complex by HDXMS and
computational docking suggests active site
coupling mediates PDE-mediated cAMP
dissociation
HDXMS studies of PDE:PKAR complexes localized the
interactions to span the cAMP-binding pockets of PKA
RIa and the regions lining the catalytic site of PDEs.
This has been observed in evolutionarily distant PDEs
tested, namely RegA and the full-length and catalytic
domain fragment of mammalian PDE8A. Although we
have chosen to focus on PDE8A for mapping interactions
with PKA RIa, our experimental studies do not preclude
similar interactions with other PDE families. The interac-
tion interface for RIa on RegA is highly conserved amongall PDEs, including the cGMP-specific PDEs. Our compu-
tational model is relevant for modeling interactions
with PKA RIa of other PDE catalytic domains as well.
On PDE8A, residues that showed decreased deuterium
exchange were mostly located proximal to the catalytic
pocket or were residues involved in dimerization
(Fig. 9 A). RIa, on the other hand, showed proteinwide de-
creases in deuterium exchange across several regions upon
complexation with PDE8AC as seen in Fig. 9 B. These
include the cAMP-binding pockets in both CNB-A and
CNB-B, the N-terminal helical subdomain, and the interdo-
main helical connector regions. However, in the cAMP-
bound state, large decreases in exchange are seen mainly
at the cAMP-binding pockets at CNB-A and CNB-B with
little effects at other regions. These two states thus repre-
sent two distinct end-point conformations of RIa consistent
with our results from docking.
Computational docking guided by results from HDXMS
provides a model for the PKA RIa:PDE8 interface. This
solution was readily generated through docking with min-
imal rearrangements in the interdomain linker of RIa.
Given the intrinsic ability of RIa to toggle between multi-
ple conformational states (33), and the high dynamics of
the interdomain C-helix, such a rearrangement is likely
through conformational selection. This work highlights
how computational docking with HDXMS and fluores-
cence spectroscopy can enable rapid mapping of theBiophysical Journal 107(6) 1426–1440
FIGURE 7 Map of the interactions of PDE8AC on RIaAB. A summary of results from the HDXMS analysis is mapped onto the structure of cAMP-bound
RIa(113–379) (PDB:1RGS). (Red shading, per key) Regions in RIa(113–379) that show significant reduction in deuterium exchange upon complex forma-
tion. (Stick representation) cAMP (C, yellow, O, red, N, blue). Mass spectra of peptides showing significant changes upon PDE8AC complex formation (dif-
ference >1 Da) are shown. The isotopic envelopes of pepsin fragment peptides of (i) undeuterated control of RIaAB, (ii) free RIaAB after 2 min deuterium
exchange, and (iii) RIaAB in a complex with PDE8AC after 2 min deuterium exchange are depicted. Centroids are indicated (:).
1436 Krishnamurthy et al.dynamics of transient interactions in multiprotein signaling
complexes.
Analysis of HDXMS data and the docking model reveals
that highly conserved residues responsible for substrate
recognition are at a close proximal distance to the cAMP
that is bound to RIa. This provides a model for mechanism
of action, whereby active site coupling between the PDE
and RIa engages residues important for cAMP binding
and allostery, thereby weakening key hydrogen bonds be-
tween RIa and cAMP. The cAMP released from RIa is sub-
sequently captured by substrate recognition residues on PDE
and is channeled into the active site to be hydrolyzed into
50AMP (Fig. 9 C, inset). The model shown here is that of
monomeric RIaAB in complex with the PDE8AC dimer.
This can be extended to model dimeric full-length RIa in
complex with two dimers of full-length PDE. We recognizeBiophysical Journal 107(6) 1426–1440that these results are specific to the truncation mutant of RIa
and catalytic domain of PDE8A, and that the presence of
additional regulatory domains might modulate PDE:PKA
interactions. PDE8 has been found to interact with PKA
C-subunit substrates to facilitate their phosphorylation
(68), and the PDE8A:RIa complex we have described
further highlights the multiple roles of PDE8 in modulating
the cAMP:PKA pathway.How do enzymes access caged substrates?
Phosphodiesterase binding facilitates cAMP dissociation
from the PKA R-subunit and catalyzes cAMP hydrolysis
An important question that is relevant to cAMP signaling is
in understanding how cAMP tightly bound to the PKA
FIGURE 8 RIaAB adopts distinct conformations in cAMP-bound and end-state complex forms. (A) (Top panel) Difference plot comparing RIaAB in the
cAMP-bound state to the apo state. Peptides in the positive range represent increased deuterium exchange in the cAMP-bound state as compared to the apo state,
whereas peptides in the negative range represent cAMP-induced protection. (Bottom panel) Difference plot comparing RIaAB in the cAMP-bound state to the
end-state complex. Peptides in the positive range indicate peptides showing decreased deuterium exchange in the end-state complex in comparison to the apo
state, whereas peptides in the negative range represent peptides showing decreased deuterium exchange in the cAMP-bound state in comparison to the end-state
complex. Peptide residue numbers, from the N- to C-terminal of RIaAB, are marked along the x axis; absolute difference in Da is marked along the y axis. Each
point represents a pepsin digest fragment and brackets groupoverlapping fragment peptides.Deuteriumexchange labeling times are colored according to key. (B)
Results from the cAMP-bound state versus the end-state complex difference plot were plotted onto the structure of RIa (PDB:1RGS). (Red regions) Greater pro-
tection in the end-state complex; (blue regions) greater protection in the cAMP-bound state. (Orange sticks) cAMP molecules, bound to CNB-A and CNB-B.
Channeling in cAMP Signal Termination by PDE-PKA Complexes 1437R-subunit is accessed by PDEs and hydrolyzed to reset the
PKA signaling system. cAMP is anchored within the target
R-subunit by a network of salt bridges and H-bonds, thereby
binding it with high affinity. By binding to cAMP with very
high affinity, PKA R-subunits function as buffers for cAMP.
The cAMP can thus be considered analogous to a caged
substrate that must first undergo dissociation before it can
be accessed by PDEs for hydrolysis. It is therefore possible
that PDE function must encompass hydrolyzing both caged
and free, unbound cytosolic cAMP.
Our results demonstrate how PDE8A binds RIa and pro-
vides a model for how it facilitates dissociation of cAMP
from both target CNB domains, highlighting how PKA
RIa might serve to buffer intracellular cAMP and channel
it to the active site of PDE8A. Substrate channeling is char-
acteristic of metabolic enzymes (69), but is being proposed
here for the first time in cAMP signaling. Sequestering of
cAMP-bound RIa by PDEs has important implications.
This allows for localized pools of cAMP to activate PKA
in microdomains. It also facilitates adaptation to steady-
state levels of cAMP by completing the cAMP cyclethrough regeneration of the inactive holoenzyme. This
also ensures that reactivation of PKAwould occur preferen-
tially upon large fluxes of cAMP levels in the cell (70).
PDE:PKA RIa interactions described are only likely to be
enhanced further by AKAPs.SUPPORTING MATERIAL
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FIGURE 9 Docking model of PDE-PKAR in-
teraction interface suggests cAMP channeling be-
tween CNB-binding sites and PDE active sites.
(A) HDXMS results of RIaAB interaction mapped
onto a surface representation of the structure
of dimeric PDE8AC where surface regions of
PDE8AC show significant decreases in deuterium
exchange upon complex formation (blue shadings).
(B) HDXMS results of PDE8AC interaction map-
ped onto a surface representation of the structure
of RIaAB, regions showing significant decreases
in deuterium exchange upon complex formation
(red shadings). (C) Docking model of the PDE8AC:
RIaAB complex highlighting proximity of the
cAMP-binding sites on the R-subunit to the PDE
active site. Proposed mechanism for channeling
in dissociation and hydrolysis of cAMP bound to
RIa. (Inset) Closeup of the PDE active site in
the model of the PDE8-RIa complex with the
PDE8 (PDB:3ECN) (blue) and RIa (113–379)
(PDB:1RGS) (gray surface representation). (Yel-
low stick representation) cAMP. Catalytic metal
ions: Zn2þ (yellow sphere) and Mg2þ (magenta
sphere) atoms are part of the hydrolytic core. (Yel-
low) Conserved residues important for substrate
recognition; (green) metal ion anchoring and hy-
drolytic center. RIa in surface representation
(only cAMP:A domain, residues 113–244, shown for clarity). A single chain of PDE8A (chain A) alone shown for clarity. Residues 662–679 have been hidden
to enable a clear view of the active site. PDE binding mediates dissociation of the phosphate of cAMP from RIa (indicated by arrow).
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